TD Asset Management Portfolio holdings
AUM
$117B
This Quarter Return
+9.35%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$72.1B
AUM Growth
+$72.1B
(+2.6%)
Cap. Flow
-$2.16B
Cap. Flow
% of AUM
-2.99%
Top 10 Holdings %
Top 10 Hldgs %
26.35%
Holding
1,433
New
113
Increased
705
Reduced
392
Closed
81
Top Buys
| 1 |
Apple
AAPL
|
$1.33B |
| 2 |
TSMC
TSM
|
$110M |
| 3 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
$105M |
| 4 |
Amazon
AMZN
|
$99M |
| 5 |
Match Group
MTCH
|
$96.1M |
Top Sells
| 1 |
Royal Bank of Canada
RY
|
$477M |
| 2 |
Toronto Dominion Bank
TD
|
$408M |
| 3 |
Scotiabank
BNS
|
$355M |
| 4 |
Canadian National Railway
CNI
|
$273M |
| 5 |
Enbridge
ENB
|
$260M |
Sector Composition
| 1 | Financials | 19.06% |
| 2 | Technology | 15.4% |
| 3 | Healthcare | 9.1% |
| 4 | Industrials | 8.83% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Schrodinger
SDGR
$1.44B
| $803K | ﹤0.01% |
16,909
| – | – |
|
1127
Generation Bio
GBIO
$40.4M
| $798K | ﹤0.01% |
25,818
+2,300
| +10% | +$71.1K |
|
1128
Harmony Biosciences
HRMY
$2.12B
| $798K | ﹤0.01% |
+23,544
| New | +$798K |
|
1129
Old Republic International
ORI
$9.93B
| $798K | ﹤0.01% |
54,125
| – | – |
|
1130
Scholar Rock
SRRK
$3.14B
| $783K | ﹤0.01% |
44,275
+21,860
| +98% | +$387K |
|
1131
Crown Holdings
CCK
$11.6B
| $782K | ﹤0.01% |
+10,179
| New | +$782K |
|
1132
Keurig Dr Pepper
KDP
$39.3B
| $781K | ﹤0.01% |
+28,302
| New | +$781K |
|
1133
Relay Therapeutics
RLAY
$619M
| $781K | ﹤0.01% |
+18,340
| New | +$781K |
|
1134
Melco Resorts & Entertainment
MLCO
$3.88B
| $774K | ﹤0.01% |
46,491
+491
| +1% | +$8.17K |
|
1135
Cytokinetics
CYTK
$5.94B
| $773K | ﹤0.01% |
+35,700
| New | +$773K |
|
1136
Intellia Therapeutics
NTLA
$1.22B
| $772K | ﹤0.01% |
38,857
+4,300
| +12% | +$85.4K |
|
1137
Zscaler
ZS
$42.7B
| $770K | ﹤0.01% |
+5,470
| New | +$770K |
|
1138
Protagonist Therapeutics
PTGX
$3.67B
| $769K | ﹤0.01% |
39,353
| – | – |
|
|
PRFT
1139
DELISTED
Perficient Inc
PRFT
| $769K | ﹤0.01% |
18,000
-16,600
| -48% | -$709K |
|
1140
Arcturus Therapeutics
ARCT
$462M
| $768K | ﹤0.01% |
17,911
| – | – |
|
1141
Semtech
SMTC
$5.04B
| $768K | ﹤0.01% |
14,500
| – | – |
|
1142
iShares China Large-Cap ETF
FXI
$6.71B
| $766K | ﹤0.01% |
18,229
+11,585
| +174% | +$487K |
|
|
AKUS
1143
DELISTED
Akouos, Inc. Common Stock
AKUS
| $758K | ﹤0.01% |
33,154
| – | – |
|
1144
Stoke Therapeutics
STOK
$1.07B
| $746K | ﹤0.01% |
22,279
| – | – |
|
1145
PG&E
PCG
$33.6B
| $744K | ﹤0.01% |
+79,200
| New | +$744K |
|
1146
Pinduoduo
PDD
$173B
| $742K | ﹤0.01% |
+10,000
| New | +$742K |
|
1147
Onto Innovation
ONTO
$5.19B
| $735K | ﹤0.01% |
24,694
-51,400
| -68% | -$1.53M |
|
1148
Zentalis Pharmaceuticals
ZNTL
$122M
| $735K | ﹤0.01% |
22,493
| – | – |
|
1149
Preferred Bank
PFBC
$1.17B
| $732K | ﹤0.01% |
22,800
+1,600
| +8% | +$51.4K |
|
|
FBMS
1150
DELISTED
The First Bancshares, Inc.
FBMS
| $731K | ﹤0.01% |
34,871
| – | – |
|